G. F. Piksina

G. F. Piksina

Auto-generated profile, based on publicly available information

G. F. Piksina

Municipal Clinical Hospital № 15 named after O. M. Filatov

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Лечащий врач
Verified
Journal Article
Closed access
AKA.I. Kochetkov
A.I. Kochetkov
IOI.YU. Orlovа
I.YU. Orlovа
OOO.D. Ostroumovа
O.D. Ostroumovа
VDV.B. Dashabylova
V.B. Dashabylova
MLM.V. Lopukhinа
M.V. Lopukhinа
GPG.F. Piksina
G.F. Piksina
Objective. The purpose of this study was to compare the structural and functional changes of the left ventricle (LV) in patients with various forms of atrial fibrillation (AF). Materials and methods. 70 patients with paroxysmal AF (group 1; median age 73 [64.75; 76.5] years, 49 (70%) women) and 54 patients with persistent or permanent forms of AF (group 2; median age 78.5 [68;83] years, 33 (61%) women) was included in the study/ All patients were underwent transthoracic echocardiography (EchoCG) using the speckle tracking technique. Results. In patients with permanent/persistent AF, compared with patients with paroxysmal AF, the several parametres were significantly lower: the stroke volume (SV) (49.2 [39.8; 57.8] ml versus 54.2 [46.2; 60.3] ml, respectively, p = 0.039), LV ejection fraction (EF) (61.4% [51.2; 67.1] versus 65.9% [61.4; 70.2], respectively, p < 0.001), absolute values of the global longitudinal LV strain (–15.1% [–18.5; –9.3] vs. –19.6% [–22.2; –16.2] respectively, p < 0.001), global LV circular strain (–16.4% [–22.9; –11.0] vs. –20.9% [–25.8; –17.6], respectively, p < 0.001), end-systolic LV elasticity (3.6 [2.7; 4.57] mmHg/ml vs. 4.3 [3.3; 5.3] mmHg/ml, respectively, p = 0.011). At the same time, the end-diastolic size (EDS), the end-diastolic volume (EDV) and its index, and the end-systolic volume (ESV) did not differ statistically significantly between the groups. Conclusion. In patients with persistent/permanent forms of AF, there is a more pronounced violation of LV systolic function compared with patients with paroxysmal AF, which manifests itself in lower values of SV, LV EF, absolute values of the global longitudinal strain and global circular strain of the LV.

25 June 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
LGL. V. Glukhacheva
L. V. Glukhacheva
OOO. D. Ostroumova
O. D. Ostroumova
ATA. A. Tyazhelnikov
A. A. Tyazhelnikov
AKA. I. Kochetkov
A. I. Kochetkov
TOT. M. Ostroumova
T. M. Ostroumova
СТС. С. Телкова
С. С. Телкова
Introduction. Atrial fibrillation (AF) is an independent risk factor for cognitive decline (CD). However, the role of iron deficiency (ID) and anemia as modifiable factors exacerbating cognitive impairment in this issue remains understudied. Aim. To assess the impact of anemia/ID on the condition of cognitive functions young and middle age patients with AF. Mat erials and methods. This cross-sectional study included 45 patients with AF (median age 53.2 [50.4; 57.2] years), divided into two groups: with anemia and/or ID (n = 23) and without (n = 22). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Trail Making Test (Parts A & B), Verbal Fluency Test, Word-List Recall, Stroop Test, Digit Span Test, and Digit Symbol Substitution Test (DSST). Anxiety and depression levels were evaluated using the Beck Anxiety Inventory (BAI) and Hamilton Depression Rating Scale (HDRS). Results. Compared to patients without anemia/ID, patients with AF and anemia/ID demonstrated significantly lower total scores on the MoCA (26 [25; 27] vs 28 [27; 28.5] points, p < 0.001) and MMSE (26 [25; 26] vs 28 [28; 29] points, p < 0.001). They also showed reduced performance in immediate word recall (4 [4; 5] vs 5 [5; 5.3] words, p = 0.032), delayed recall (3 [3; 3.3] vs 4 [4; 5] words, p < 0.001), and the letter fluency test (13 [12.8; 14] vs 14 [13; 15] words, p = 0.013). Psychomotor speed was slower on the DSST (46 [41; 50] vs 55 [44.8; 65] points, p = 0.011), attention was worse on the Digit Span Test (4 [4; 4.3] vs 5 [4.8; 5.3] points, p = 0.005), and execution time was longer for Trail Making Test Part A (61.5 [57.8; 63.8] vs 50 [45; 57.3] s, p < 0.001) and Part B (79.5 [74; 92] vs 69 [64; 77] s, p < 0.001). Conclusions. Anemia/ID in young and middle-aged patients with AF is associated with multiple cognitive deficits, which justifies the need for screening of iron metabolism and hemoglobin levels in this patient population.

3 May 2026 in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Verified
Journal Article
Open access
PDF file
ESEvgenia Shikh
Evgenia Shikh
SES. S. Eremina
S. S. Eremina
OOO. D. Ostroumova
O. D. Ostroumova
SLS. V. Litvinova
S. V. Litvinova
GPG. F. Piksina
G. F. Piksina
EEE. Yu. Ebzeeva
E. Yu. Ebzeeva
Background. In clinical practice, elderly patients often present with multiple comorbidities. The combination of atrial fibrillation (AF) and chronic kidney disease (CKD), particularly with a progressive decline in glomerular filtration rate (GFR), poses a significant challenge for selecting rational pharmacotherapy. Objective. To analyze the structure of drug therapy in patients aged over 65 years with AF and stage 4 CKD treated in internal medicine departments of a multidisciplinary hospital in 2018–2019 and 2022–2023 for compliance with the STOPP/START criteria. Materials and methods. The study included data from 86 patients, stratified into two groups: Group 1 comprised 27 patients (median age 87 [82; 89] years; 81.5 % women) hospitalized in 2018–2019; Group 2 included 59 patients (median age 91 [87; 93] years; 78 % women) treated in 2022–2023. Results. The prevalence of STOPP criteria was significantly higher in Group 2 compared to Group 1: 64.4 % vs. 51.9 %, respectively (p = 0.03). The most frequently identified STOPP criterion was the use of drugs with anticholinergic activity for chronic constipation (18.5 % in Group 1 vs. 30.5 % in Group 2, p = 0.37). Omissions of indicated therapy (START criteria) were common in both groups: 96.3 % in Group 1 and 76.3 % in Group 2 (p = 0.39). The most common START criterion was the absence of statin therapy in patients with a history of coronary, cerebral, or peripheral vascular disease. This omission was significantly more frequent in Group 1 than in Group 2 (85.2 % vs. 23.7 %, p < 0.001). Conclusion . The pharmacotherapy of polymorbid patients over 65 years with AF and stage 4 CKD requires further optimization. The findings highlight the critical need for broader and regular application of the STOPP/START criteria in multidisciplinary hospital settings to optimize pharmacotherapy in older polymorbid patients.

25 October 2026 in Medical alphabet
Verified
Journal Article
Open access
PDF file
LGL. V. Glukhacheva
L. V. Glukhacheva
OOO. D. Ostroumova
O. D. Ostroumova
ASA. Ya. Starokozheva
A. Ya. Starokozheva
AKA. I. Kochetkov
A. I. Kochetkov
GPG. F. Piksina
G. F. Piksina
СТС. С. Телкова
С. С. Телкова
Background. The clinical significance of anemia and iron deficiency (ID) in patients with atrial fibrillation (AF) is currently undetermined and requires further investigation. Objective. Analysis of the effect of anemia/ID on physical performance and quality of life in young and middle-aged patients with AF. Materials and methods. This cross-sectional, comparative study included 45 patients with AF (84.4 % male), who were divided into two groups: those with anemia and/or ID (n=23) and those without these conditions (n=22). Physical performance was assessed using a treadmill test and the six-minute walk test, while quality of life was evaluated using the SF-36 questionnaire. Results. Patients with AF and anemia/ID demonstrated lower peak exercise capacity compared to those without these conditions (4.8 [3.2; 5.5] vs. 7.0 [6.2; 9.2] METs, p<0.001); a higher proportion of patients without anemia/ID reached submaximal heart rate compared to those with anemia/ID (59 % and 22 %, respectively, p=0.028). A greater number of patients in the anemia/ID group exhibited low exercise tolerance compared to the nonanemic/non-ID group (70 % and 27 %, respectively, p=0.006). In the six-minute walk test, patients with anemia/ID covered a shorter distance than those without anemia/ID (765 [697.5; 837.5] vs. 905 [857; 995] meters, p<0.001). In patients with AF and anemia/ID, the final score for the Physical Component Summary (PCS) of health was statistically significantly lower compared to the group without anemia/ID (45.5 [39.7; 49.8] vs. 55 [45; 58] points, p=0.007). A similar result was observed when assessing the Mental Component Summary (MCS) of health (38 [33.5; 44.5] vs. 45 [40.8; 49] points, p=0.024). Conclusions. In young and middle-aged patients with AF, the presence of anemia and/or ID leads to decreased physical performance and reduced quality of life.